Press Release

Connect Biopharma Reports Positive Phase 1 Data and Announces Initiation of Phase 1b Study in Patients with Atopic Dermatitis for Novel IL-4Rα Antibody CBP-201

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *